top of page
Selene Therapeutics
Focuses on developing small molecule inhibitors to regulate neuronal activity, offering new therapeutic strategies for treating refractory epilepsy through mitochondrial enzyme modulation.
Company Name | Neurotech Category | Market Category | Company Founded Year | Company Location |
|---|---|---|---|---|
Selene Therapeutics | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | 2020 | Ness Ziona |
Focuses on developing small molecule inhibitors to regulate neuronal activity, offering new therapeutic strategies for treating refractory epilepsy through mitochondrial enzyme modulation.
bottom of page